Curative Biotechnology, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 3.96 million compared to USD 5.38 million a year ago. Basic loss per share from continuing operations was USD 1 compared to USD 1 a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.019 USD | +11.76% | 0.00% | -10.80% |
1st Jan change | Capi. | |
---|---|---|
-10.80% | 17.16M | |
+53.15% | 55.7B | |
+40.29% | 39.91B | |
-6.70% | 39.57B | |
-6.65% | 28.16B | |
+14.55% | 26.3B | |
-20.28% | 18.94B | |
+30.60% | 12.17B | |
+26.67% | 12.12B | |
+0.38% | 12.12B |
- Stock Market
- Equities
- CUBT Stock
- News Curative Biotechnology, Inc.
- Curative Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023